Riskpilot← Back to searchSign inGet full accessHRMed Oy
OYDissolvedY-tunnus 3012144-4Lankalenkki 10Medical specialists activities · NACE 8622Est. 20193112 employees
Revenue 2025
EUR 891K
-2% vs 2024
EBITDA margin
36.8%
-79% vs 2024
Equity ratio
97.5%
Financial strength
Net profit 2025
EUR 260K
+17% vs 2024
| Revenue | EUR 891K | -2% |
| EBITDA | EUR 328K | -79% |
| Net profit | EUR 260K | +17% |
| Total assets | EUR 900K | +22% |
| Equity | EUR 877K | +30% |
| Employees | 3112 | — |
Legal name
HRMed Oy
Y-tunnus number
3012144-4
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
11. heinäkuuta 2019
Share capital
EUR 0
Employees
3112 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Toimitusjohtaja yksin
Company purpose
Lääkäri. Sijoitustoiminta, kuten startup-, yritys-, osake-, rahasto ja asuntosijoittaminen.
Address
Lankalenkki 10
Email
hjtristo@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | 365 | 420 | 470 | 483 | 905 | 891 |
| Staff expenses | −172 | −172 | −172 | −160 | 202 | −144 |
| EBITDA | 152 | 145 | 187 | 199 | 1 557 | 328 |
| Depreciation & amort. | −1 | −2 | −1 | −1 | 1 | −3 |
| EBIT | 152 | 143 | 186 | 197 | 273 | 325 |
| Net financials | −0 | −0 | 4 | 7 | — | −0 |
| Profit before tax | 151 | 143 | 189 | 204 | 277 | 324 |
| Tax | 31 | 29 | 38 | 42 | 55 | 65 |
| Net profit | 121 | 114 | 151 | 162 | 221 | 260 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 160 | 260 | 403 | 542 | 739 | 900 |
| Equity | 121 | 225 | 358 | 492 | 673 | 877 |
| Long-term debt | — | — | — | 0 | — | 0 |
| Short-term debt | 39 | 35 | 45 | 50 | 66 | 23 |
| Total debt | 39 | 35 | 45 | 50 | 66 | 23 |
EBITDA margin
36.8%
This company
15.8%
Market median
+133% vs market
20202025
Equity ratio
97.5%
This company
38.2%
Market median
+155% vs market
20202025
Return on equity
29.6%
This company
18.4%
Market median
+61% vs market
20202025
Net profit margin
29.1%
This company
8.1%
Market median
+259% vs market
20202025
Asset turnover
0.99×
This company
1.12×
Market median
+12% vs market
20202025
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20202025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2019-07-01 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HJ Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
MS Deputy auditor | Deputy auditor | 2021 | — | — |
IA Deputy Member | Deputy Member | 2019 | — | — |
JP Audit | Audit | 2021 | — | — |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HRMed Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Heikki Juha Tapani Ristolainen | Chief Executive Officer | 0 companies |
| Martta Siiri Maria Hakala | Deputy auditor | 0 companies |
| Irkka Airola | Deputy Member | 0 companies |
| Juha Pekka Siikavuo | Audit | 0 companies |